Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-38.61	52.91	86.19
Graham Fair Price	47.40	27.65	18.76
PEG	-90.74	0.20	-2.20
Price/Book	5.51	5.62	5.33
Price/Cash Flow	60.55	216.94	135.12
Prices/Earnings	-55.50	24.13	54.24
Price/Sales	-1.27	16.66	16.88
Price/FCF	60.55	216.94	135.12
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.59	0.75	0.73
Operating Margin	139.48	0.26	0.11
ROA	124.23	0.02	< 0.005
ROE	0.02	0.06	137.12
ROIC	0.02	0.04	68.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.21	< 0.005	106275.40
Dividends QOQ	-1.00	1515.50	151665.27
EBIT QOQ	-0.33	1.45	345.90
EPS QOQ	-0.25	1.19	380.65
FCF QOQ	-0.31	-0.37	-19.50
Revenue QOQ	0.07	0.02	-68.66
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	144.22	153.39	6.36
Days Sales Outstanding (DSO)	86.94	87.10	0.19
Inventory Turnover	0.62	0.59	-5.98
Debt/Capitalization	0.41	0.47	13.95
Quick Ratio	0.59	0.70	19.55
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25.23	24.16	-4.27
Cash	3.84	5.17	34.62
Capex	-0.62	-1.03	-65.67
Free Cash Flow	1.00	0.63	-37.09
Revenue	7.97	8.15	2.31
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.82	0.89	7.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.49	5.96	-29.81
Naive Interpretation	Member

06 - Financial Health · Bad

Rating